Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Sanofi India Ltd (SANO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8,620.00 -57.75    -0.67%
03/05 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE058A01010 
S/N:  SANOFI
  • Volume: 31,763
  • Bid/Ask: 8,619.00 / 8,620.00
  • Day's Range: 8,501.00 - 8,691.00
Sanofi India 8,620.00 -57.75 -0.67%

Sanofi India Ltd Company Profile

 
Get an in-depth profile of Sanofi India Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

2505

Equity Type

ORD

Sanofi India Limited is a healthcare company. The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It offers a range of medicines and supplements for treatment of diabetes (both insulin and orals), cardiology, thrombosis, epilepsy, allergies, and infections. It has two manufacturing sites, one in Hyderabad and one in Goa. Its geographical segments include India, Singapore, and Others. It sells its products through independent distributors primarily in India. It also manufactures its products through third party manufacturers. The different types of dosage forms include tablets, capsules (hard and soft), eye/ear drops, ampoules, vials, creams, and ointment. Its brands include Lantus, Allegra, and Combiflam. Its vaccine products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT. Its consumer healthcare products include Allegra, Allegra nasal, and Avil.

Contact Information

Address Sanofi House CTS No. 117-B, L&T Business Park
Saki Vihar Road Powai Mumbai, 400072
India
Phone 91 22 2803 2000
Fax 91 22 2803 2939

Top Executives

Name Age Since Title
Aditya Narayan 69 2016 Independent Non-Executive Chairman
Rodolfo Hrosz - 2022 MD & Director
Usha Thorat 73 2016 Independent Non-Executive Director
Rahul Bhatnagar 65 2020 Independent Director
Vaibhav Karandikar 50 2020 Non-Executive Director
Renee Amonkar - 2023 Additional Whole Time Director
Rachid Ayari - 2023 CFO & Whole Time Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SANO Comments

Write your thoughts about Sanofi India Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dhananjay Pandey
Dhananjay Pandey Jul 20, 2021 12:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
not sure to go high because delay in vaccines launch ..sanofi brands are moving due to price hike
Virendra Shah
Virendra Shah Jul 12, 2021 2:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
we may see 9000 in Sept/Octo this year.....!
Saba Arrunachalam
Saba Arrunachalam Jul 12, 2021 2:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Today I bought. But your prediction happened in Aug 2021 itself. Great.
Virendra Shah
Virendra Shah Apr 26, 2021 3:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Vaccines candidate,wl be five digit....
Virendra Shah
Virendra Shah Apr 26, 2021 3:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy.. Buy...Buy...
Virendra Shah
Virendra Shah Apr 09, 2021 10:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
slow,but solid move....
Rajesh Patel
Rajesh Patel Mar 18, 2021 1:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
expecting revenue growth increase
Rajesh Patel
Rajesh Patel Mar 18, 2021 1:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
expecting revenue growth increase
Sudhakar Babu
Sudhakar Babu Jun 11, 2018 4:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
expecting bonus and stock split in the coming year
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email